Our Pipeline
The TB Alliance and its partners manage the largest pipeline of TB drugs in history.
Click on the link below to download a .pdf of our latest pipeline and list of partners.
The TB Alliance currently manages more than 20 projects in its pipeline, including three drug candidates and a novel multi-drug regimen in late-stage clinical trials. A faster-acting, better TB drug regimen will improve patient compliance, increase cure rates, lower toxic side effects, and could save millions of lives. As new treatments are developed, the TB Alliance hopes to reduce the time to cure TB from the current treatment duration — from six months to two years — to our ultimate goal: a TB treatment that can be administered in less than two weeks, similar to those for many other bacterial infections.
The Challenge of New Drug Discovery for Tuberculosis
This article from the 27 January 2011 Nature discusses innovations in TB drug discovery and evolving strategies to bring newer agents more quickly to patients.
Article authors: Anil Koul, Eric Arnoult, Nacer Lounis, Jerome Guillemont & Koen Andries